ARYLAMINE ACTIVATING SULFOTRANSFERASE IN LIVER
Citation
K. Nagata et al., ARYLAMINE ACTIVATING SULFOTRANSFERASE IN LIVER, Mutation research, 376(1-2), 1997, pp. 267-272
Categorie Soggetti
Genetics & Heredity",Biology,"Biothechnology & Applied Migrobiology
SICI code
0027-5107(1997)376:1-2<267:AASIL>2.0.ZU;2-8
Abstract
Carcinogenic N-hydroxy-arylamines and -arylamides undergo metabolic ac
tivation by several enzymes in mammals to cause the DNA damage. Cytoso
lic sulfotransferases in rat and human livers, which belong to the ST1
(SULT1) family, have been studied to assess their properties to media
te the metabolic activation. A human orthologue of rat ST1C1 form, whi
ch catalyzes sulfation of N-hydroxy-2-acetylaminofluorene, was screene
d in a EMBL genomic library with ST1C1 cDNA [Nagata, K., S. Ozawa, M.
Miyata, M. Shimada, D.-W. Gong, Y. Yamazoe and R. Kato (1993) J. Biol.
Chem., 268, 24720-24725]. Sequencing of the hybridized clones indicat
e that at least 3'-terminal region of human ST1C1 orthologue contains
sequence highly homologous to rat ST1C1 at both nucleotide and deduced
amino acid levels. The experiments using anti-rat ST1C1 antibody and
nucleotide probes for human ST1C1 showed no detectable band in Western
blots and an mRNA-detecting method with polymerase chain reaction, re
spectively, in human liver samples.